Joseph C. Galante, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 1,560 shares at $2.33 ($4K) on 2022-10-17, disclosed to the SEC on 2022-11-18.
Scheduled purchase ($4k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.52 | 65 | $164 | 4.2% |
| 2 | $2.51 | 65 | $163 | 4.2% |
| 3 | $2.61 | 65 | $170 | 4.4% |
| 4 | $2.54 | 65 | $165 | 4.2% |
| 5 | $2.61 | 65 | $170 | 4.4% |
| 6 | $2.58 | 65 |
| $168 |
| 4.3% |
| 7 | $2.65 | 65 | $172 | 4.4% |
| 8 | $2.66 | 65 | $173 | 4.4% |
| 9 | $2.53 | 65 | $164 | 4.2% |
| 10 | $2.48 | 65 | $161 | 4.1% |
| 11 | $2.49 | 65 | $162 | 4.2% |
| 12 | $2.38 | 65 | $155 | 4.0% |
| 13 | $2.31 | 65 | $150 | 3.9% |
| 14 | $2.33 | 65 | $151 | 3.9% |
| 15 | $2.46 | 65 | $160 | 4.1% |
| 16 | $2.42 | 65 | $157 | 4.0% |
| 17 | $2.44 | 65 | $159 | 4.1% |
| 18 | $2.49 | 65 | $162 | 4.2% |
| 19 | $2.38 | 65 | $155 | 4.0% |
| 20 | $2.44 | 65 | $159 | 4.1% |
| 21 | $2.42 | 65 | $157 | 4.0% |
| 22 | $2.49 | 65 | $162 | 4.2% |
| 23 | $2.52 | 65 | $164 | 4.2% |
| 24 | $2.54 | 65 | $165 | 4.2% |
| Total | $2.49 avg | 1,560 | $4K | 100% |
| Filing → |
| CPIX | BUY | 2022-12-23 | $3K | — | Filing → |
| CPIX | BUY | 2022-09-30 | $5K | — | Filing → |
| CPIX | BUY | 2022-08-19 | $5K | — | Filing → |